Zymergen Inc. (ZY) est une société cotée en bourse dans le Matériaux de Base secteur, opérant dans le Chemicals - Specialty secteur d'activité. Le siège social de l'entreprise est situé à EmeryVille, CA, United States. Le PDG actuel est Joshua J. Hoffmann.
ZY a date d'introduction en bourse 2021-04-22, 502 employés à temps plein, cotée sur le NASDAQ Global Select.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
